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Introduction
Dendrite morphogenesis requires an intrinsic differentiation 
program that is guided by extracellular cues and electrical ac-
tivity. These different forces converge to control the gene ex-
pression and cytoskeletal dynamics that specify dendrite growth 
and branching, as well as dendritic spine formation (Scott and 
Luo, 2001; Whitford et al., 2002; Jan and Jan, 2003; Miller 
and Kaplan, 2003; Van Aelst and Cline, 2004). Various small 
GTPases act as key regulators in dendrite development (Scott and 
Luo, 2001; Gao and Bogert, 2003). The Rho family GTPases, 
such as RhoA, Rac1, and Cdc42, regulate actin dynamics and pro-
foundly infl  uence dendrite morphogen  esis (Cline, 2001; Redmond 
and Ghosh, 2001; Luo, 2002). Another small GTPase Ras family 
is also important for activity-dependent fi  lopodia formation 
and dendritic complexity via the activation of a MAPK signaling 
pathway (Wu et al., 2001; Koh et al., 2002; Redmond et al., 2002; 
Goldin and Segal, 2003; Alonso et al., 2004). Recent studies indi-
cate that the Ras–phosphatidylinositol 3-kinase–Akt–mammalian 
target of the rapamycin signaling pathway has a pivotal role 
in regulating dendrite formation (Jaworski et al., 2005; Kumar 
et al., 2005). These small GTPases undergo structural changes 
in response to alternative binding of GDP and GTP: activation 
by GTP requires guanine nucleotide exchange factor (GEF), and 
inactivation requires GTPase-activating protein (GAP) (Cherfi  ls 
and Chardin, 1999). The GTP-bound active form interacts 
with downstream effectors to activate cell signaling pathways, 
including that in dendrite morphogenesis (Goi et al., 1999; Yang 
and Mattingly, 2006).
Various signaling pathways underlying dendrite devel-
opment eventually affect the dynamics of actin fi  laments or 
microtubules (MTs) or both during dendrite growth. The high 
molecular weight MAP2 (referred to hereafter as MAP2) family 
proteins are an abundant group of MT-associated proteins that 
are predominantly expressed in neurons (Friedrich and Aszodi, 
1991) and are selectively enriched in the soma and dendrites 
(Bernhardt and Matus, 1984). In dendrites, MAP2 is a major 
component of the cross-bridges between MTs, or between MTs 
and other cytoskeletal components (Shiomura and Hirokawa, 
1987; Hirokawa et al., 1988). In MAP2-defi  cient mice, the 
dendrites have a reduced MT density, and are shorter in hippo-
campal neurons (Harada et al., 2002). Moreover, MAP2 can be 
highly phosphorylated and is thought to act as a phosphorylation-
dependent modulator of MTs during dendrite development 
(Sanchez et al., 2000). The details of the molecular mechanisms 
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underlying these cytoskeletal regulations, however, are not 
fully understood.
Very-KIND protein (v-KIND) was fi  rst characterized as 
a nervous system–specifi  c protein carrying two kinase non-
catalytic C-lobe domains (KINDs), a RasGEF N-terminal domain 
(RasN), and a putative RasGEF domain (Mees et al., 2005). 
The functional role of this new class of RasGEF v-KIND is 
largely unknown. In this study, we identifi  ed v-KIND as a 
transcript with up-regulated, brain-specifi  c, and cerebellum-
dominant expression profi  les by transcriptomic analysis of post-
natal mouse cerebellum (Cerebellar Development Transcriptome 
Database [CDT-DB] project, http://www.cdtdb.brain.riken.jp). 
v-KIND was expressed during mouse brain development and 
interacted with Ras and MAP2. Overexpression of v-KIND 
suppressed dendrite growth, leading to simple branching pat-
terns. In contrast, knockdown of v-KIND expression by RNA 
interference (RNAi) led to more complicated dendrite branch-
ing patterns. The results of the present study suggest that 
v-KIND is important for the control of dendrite growth. v-KIND 
is the fi  rst RasGEF known to bind to MAP2, thereby provid-
ing a new mechanism to link the Ras GTPase signaling path-
way and MAP2-MT cytoskeletal organization during dendrite 
morphogenesis.
Results
v-KIND is a novel RasGEF protein 
predominantly expressed in postnatal 
mouse brain
We fi rst identifi  ed a transcript with an up-regulated and brain-
specifi  c expression profi  le (CDT-DB clone number CD01268; 
GenBank/EMBL/DDBJ accession no. BP427523) in the tran-
scriptomic analysis of cerebellar development, and cloned it as 
a mouse v-KIND gene (GenBank accession no.: AJ580324). 
v-KIND encoded a 1,742-amino acid protein that included 
two KIND domains (KIND1 and KIND2), a coiled-coil re-
gion, a Ras GEF N-terminal (RasN) domain, and a RasGEF 
domain (Fig. 1 A).
Analysis of eight postnatal day (P) 21 mouse tissues showed 
that v-KIND mRNA was predominantly expressed in the brain 
(Fig. 1 B). Expression of v-KIND mRNA in P7 mouse brain was 
very low and barely detected in the other tissues (unpublished 
data). Temporal expression analysis in developing mouse cere-
bellum revealed that the expression of v-KIND mRNA was sharply 
up-regulated between P7 and P12 (Fig. 1 C).
Cellular localization of v-KIND mRNA in P7 and P21 
mouse brain was analyzed by in situ hybridization (Fig. 1, D 
Figure 1.  v-KIND was predominantly expressed in developing mouse cerebellum. (A) Domain structure of v-KIND protein. (B) RT-PCR analysis of v-KIND 
mRNA expression in P21 mouse tissue. (C) RT-PCR analysis of v-KIND mRNA expression in postnatal cerebellum at six different stages. RT-PCR for GAPDH 
was used as an internal control. (D and E) In situ hybridization analysis of v-KIND distribution in the P7 (D) and P21 (E) mouse brain. Bar, 1 mm. 
(F) Immunoblotting of v-KIND in the postnatal cerebellum. Equal amounts of protein lysates from mouse cerebellum at six postnatal stages (P0, P3, P7, P12, 
P21, and P56) were subjected to immunoblotting analysis by a speciﬁ  c antibody generated against v-KIND protein. (G) Immunohistochemical staining 
of v-KIND in P21 mouse brain sections. Bar, 1 mm. (H) In situ hybridization analysis of v-KIND distribution in whole cerebellum; Bar, 1 mm. (I) Immuno-
labeling of v-KIND protein in mouse cerebellum. (J) In situ hybridization analysis of v-KIND distribution in the cerebellar cortex; Bar, 100 μm. ML, molecular 
layer; PL, Purkinje cell layer; IGL, internal granule cell layer; WM, white matter. (K) Immunolabeling of v-KIND protein in cerebellar cortex. (L) Magniﬁ  ed 
image of granule cells in the IGL as indicated in the rectangle in (K); Bar, 10 μm. Asterisks indicate synaptic glomeruli. (M and N) Immunolabeling of 
v-KIND protein in mouse hippocampus. M, whole hippocampus; Bar, 100 μm. N, v-KIND immunolabeling in pyramidal neurons in the CA1 region; 
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and E, H, and J). At P7, v-KIND mRNA expression levels were 
generally low throughout the brain, but high in hippocampus, 
thalamus, and the cerebellar white matter (Fig. 1 D). At P21, 
v-KIND mRNA was detected in nearly all fi  elds at varying inten-
sities (Fig. 1 E): it was predominantly localized in the cerebellum, 
and was observed at intermediate levels in the hippocampus and 
thalamus (Fig. 1 E). In the cerebellum, v-KIND mRNA was con-
centrated in the internal granular layer (IGL) and expression was 
higher in the anterior lobe than in the posterior lobe (Fig. 1 H). 
v-KIND mRNA was predominantly observed in granule cells, 
and was expressed in cells within the white matter (Fig. 1 J). 
These developmentally regulated and region-specifi  c expression 
patterns suggest that v-KIND is responsible for specifi  c devel-
opmental events in postnatal mouse brain.
Distribution of v-KIND protein in P21 
mouse brain
We investigated v-KIND protein expression in developing mouse 
brains using an antibody that specifi  cally recognizes v-KIND 
protein. The specifi  city of the antibody is shown in Fig. S1 (avail-
able at http://www.jcb.org/cgi/content/full/jcb.200702036/DC1). 
The v-KIND protein level was greatly increased by P21 (Fig. 1 F), 
which almost paralleled the mRNA expression pattern (Fig. 1 C). 
Subcellular fractionation analysis of P7 and P21 mouse cere-
bella shows that v-KIND protein is a soluble protein but appears 
to associate with precipitable components, such as cell mem-
branes or cytoskeletal elements (Fig. S1 B).
The cellular distribution of v-KIND protein in mouse 
brain was analyzed using immunohistochemistry (Fig. 1, G, I, 
and K–N). Widespread immunolabeling patterns of v-KIND were 
observed in the P21 mouse brain (Fig. 1 G). Intense immuno-
labeling signals were detected in the IGL of the cerebellum 
(Fig. 1 I) and moderate immunolabeling signals were observed 
in the hippocampus (Fig. 1 M), which was consistent with the 
Western blotting data, showing that v-KIND is more abundant 
in cerebella than hippocampus (Fig. S1 C). In the cerebellum, 
there was more v-KIND protein in the anterior lobe than in 
the posterior lobe (Fig. 1 I), which was similar to the mRNA 
distribution pattern (Fig. 1 H). In the IGL, v-KIND protein was 
predominantly observed around the periphery of the granule 
cells and in the glomerular rosette areas, indicating that v-KIND 
protein expressed in granule cells is largely localized in the 
somatodendritic region (Fig. 1 L). In the hippocampus, v-KIND 
protein was distributed in the CA1-CA2-CA3 region (Fig. 1 M) 
and was localized in the soma and dendrites of CA1 pyramidal 
neurons (Fig. 1 N).
v-KIND has GEF activity for Ras and binds 
to activated Ras
To investigate the function of the RasGEF domain of v-KIND, 
we analyzed the interaction between v-KIND and Ras. v-KIND 
coimmunoprecipitated with Ras from cerebellar lysates (Fig. 2 A). 
This interaction was verifi  ed by an exogenous expression system 
in COS7 cells (Fig. 2 B). The expressed FLAG-tagged v-KIND 
was coimmunoprecipitated with endogenous Ras by the anti-Ras 
antibody, whereas the mutant lacking the RasGEF domain (∆GEF), 
failed to be precipitated. These results suggest that v-KIND is 
associated with Ras through the RasGEF domain.
The RasGEF activity of v-KIND was then investigated by 
the pull-down assay using the GST-fused Raf-1 Ras binding 
domain (RBD), which specifi  cally binds to the activated GTP-
bound form of Ras (Ras-GTP). Coexpression of H-Ras with 
v-KIND in COS7 cells showed increased immunoreactivity for 
H-Ras-GTP pulled-down by the Raf-1 RBD in comparison with 
expression of H-Ras alone (Fig. 2 C), indicating that co  expressed 
v-KIND has potential RasGEF activity.
Figure 2.  v-KIND protein acts as a Ras GEF in 
mouse cerebellum. (A) Coimmunoprecipitation of 
Ras with v-KIND from mouse cerebellar lysates. 
Equal amounts of cerebellar lysates from P21 mice 
were immunoprecipitated with the anti-Ras anti-
body and immunoblotted with the anti-v-KIND anti-
body. (B) RasGEF domain was responsible for 
v-KIND-Ras association. Equal amounts of protein 
lysates from COS7 cells expressing FLAG-tagged 
v-KIND or a v-KIND mutant lacking the RasGEF do-
main (∆GEF) were immunoprecipitated with the 
anti-Ras antibody and immunoblotted with the 
anti-FLAG antibody (top panel). Middle panel, Ras in 
the immunoprecipitates. Bottom panel, FLAG-tagged 
v-KIND and ∆GEF in whole lysates. (C) v-KIND 
activated H-Ras. Activated H-Ras (GTP-Ras) in cells 
with or without FLAG-tagged v-KIND coexpression 
was analyzed by pull-down assay using GST-Raf-1-
RBD. The protein complex was then subjected to 
immunoblotting with anti-Ras and anti-FLAG anti-
body. (D) Binding of v-KIND to Ras-GDP and Ras-
GTP. Equal amounts of mouse hippocampal protein 
lysate were treated by GDP-β-S or GTP-γ-S, and 
then investigatedby Raf-1 RBD pull-down assay. 
Top panel, v-KIND binding with Ras in the pres-
ence of GDP-β-S or GTP-γ-S; Bottom panel, the 
quantity of GTP-Ras. (E) GST-Raf-1-RBD pulled down activated GTP-Ras (second panel) together with FLAG-tagged v-KIND, but not ∆GEF (top panel). (F) v-KIND 
protein was pulled down with GTP-Ras by GST-Raf-1-RBD from mouse cerebellum. Top panel, v-KIND in the pull-down lysate; bottom panel, activated Ras 
in the pull-down lysate.JCB • VOLUME 179 • NUMBER 3 • 2007  542
The RasGEF domain has binding affi  nity for both Ras-GDP 
and Ras-GTP (Cherfi  ls and Chardin, 1999). We investigated the 
binding of v-KIND to Ras in hippocampal lysates in the pres-
ence of either GDP-β-S or GTP-γ-S (Fig. 2 D). In general, 
GDP-β-S inhibits the production of Ras-GTP, whereas GTP-γ-S 
activates it (Taylor et al., 2001). The quantity of Ras-GTP was 
measured by Raf-1 RBD pull-down assay. As expected, the 
immunoreactivity for Ras-GTP pulled-down by the Raf-1 RBD 
was higher in the presence of GTP-γ-S than in the presence of 
GDP-β-S (Fig. 2 D, bottom). In addition, the presence of GTP-
γ-S increased the amount of v-KIND coimmunoprecipitated 
with anti-Ras antibody in comparison with that of GDP-β-S 
(Fig. 2 D, top), indicating that v-KIND binds to both Ras-GDP 
and Ras-GTP, but binds more preferentially to Ras-GTP.
We compared the binding specifi  city of v-KIND and 
∆GEF to H-Ras by the Raf-1 RBD pull-down assay. v-KIND 
together with H-Ras was pulled down by Raf-1 RBD from lysates 
of COS7 cells coexpressing H-Ras and v-KIND, whereas ∆GEF 
was not pulled down by Raf-1 RBD from lysates of cells co-
expressing H-Ras and ∆GEF (Fig. 2 E). These results suggest that 
the RasGEF domain of v-KIND has RasGEF activity and a 
major region responsible for the interaction with the activated Ras.
We verifi  ed the in vivo association of endogenous v-KIND 
and activated Ras in mouse hippocampal lysates (Fig. 2 F). 
In contrast to GST alone (as a negative control), GST-Raf-1 
RBD pulled down v-KIND as well as Ras. Similarly, in contrast 
to control mouse IgG, the anti-Ras antibody coimmunoprecipitated 
v-KIND and Ras. Collectively, these results suggest that v-KIND 
acts as a RasGEF in mouse brain.
Localization of v-KIND in dendrites and 
soma of primary cultured neurons
Subcellular localization of v-KIND was analyzed by immuno-
cytochemistry in primary cultured neurons. In cerebellar gran-
ule cells at 14 days in vitro (DIV), v-KIND was distributed 
prominently in the soma and punctately in dendrites as marked 
by anti-MAP2 antibodies (Fig. S1 D). Because the dendrites of 
hippocampal neurons are easier to visualize than the dendrites 
of cerebellar granule cells, we compared the expression patterns 
of v-KIND with those of MAP2 at various differentiation stages 
in hippocampal primary cultures (DIV3, 6, 10, 15, and 21). 
  Immunoblotting analysis revealed that the expression level of 
v-KIND gradually increased and peaked at DIV15, which 
was similar to that of MAP2 (Fig. 3 A). Immunocytochemical 
Figure 3.  v-KIND protein is enriched in the dendritic shafts in primary cultured neurons. (A) Immunoblotting of v-KIND protein in primary cultured hippo-
campal neurons at DIV3, DIV6, DIV10, DIV15, and DIV21. MAP2 was used as a control. (B) v-KIND protein (green) distribution in primary cultured hippo-
campal neurons at DIV6, DIV10, DIV15, and DIV21. Dendrites were marked by anti-MAP2 antibody (red). Images were captured by confocal microscopy 
(Carl Zeiss MicroImaging, Inc.). Bar, 100 μm. (C) Costaining of v-KIND (green) with MAP2 (red) in the dendritic shaft of hippocampal neurons at DIV21. 
(D) Costaining of v-KIND (green) with MAP2 (blue) and F-actin (phalloidin, red) in dendrites of hippocampal neurons at DIV10. Arrow, colocalized v-KIND 
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analysis showed v-KIND immunoreactivity almost overlapped 
with MAP2 immunoreactivity in soma and dendrites and was 
not localized to axons throughout differentiation (Fig. 3 B). 
Immunostaining patterns around the dendrite shafts differed 
between v-KIND and MAP2: v-KIND immunoreactivity appeared 
as many small puncta around the dendrites, although MAP2 
immunoreactivity appeared very heavily and smoothly on the 
dendrites (Fig. 3 C). In DIV10 cultures, v-KIND immuno-
reactivity was also observed in the more distal tips of the den-
drites, which were MAP2-negative, but F-actin positive (Fig. 3 D).
Overexpression of v-KIND impairs dendritic 
growth of hippocampal neurons
Because Ras family proteins regulate dendrite morphogenesis, 
we investigated the function of v-KIND in dendrite growth 
by overexpressing v-KIND in hippocampal primary cultures. 
Based on the fact that peak dendritic outgrowth occurs at DIV6-7 
(Dotti et al., 1988), and taking into account transfection effi  -
ciency and post-transfection expression levels, hippocampal 
cultures were cotransfected with pCAG-v-KIND plus pCAG-
EGFP (as a conventional reporter for cell morphology) at DIV3, 
and their dendrite morphology was observed at DIV11, DIV15, 
and DIV21. At DIV11, cells expressing EGFP alone exhibited 
normal dendrite growth with long branches, whereas v-KIND 
plus EGFP-overexpressing cells had a severely retarded den-
dritic pattern with very short protrusions (Fig. 4 A). At DIV11, 
v-KIND overexpression signifi  cantly reduced the number of 
cells with dendrites longer than 50 μm long ( 39% of cells with 
v-KIND overexpression vs  70% with EGFP alone; Fig. 4 B; 
P < 0.001) and signifi  cantly decreased total dendrite length per 
cell (378 ± 153 μm with v-KIND vs 999 ± 463 μm with 
EGFP alone; Fig. 4 C; P < 0.001). At DIV15, v-KIND–over-
expressing cells had a few long, but less-branched dendrites 
and many short dendrites, whereas cells expressing EGFP alone 
had longer, branched dendrites (Fig. 4 A). Total dendrite length 
of individual v-KIND-overexpressing cell (599 ± 258 μm) 
was approximately two times shorter than that of cells ex-
pressing EGFP alone (1,156 ± 433 μm; Fig. 4 C). At DIV21, 
cells expressing EGFP alone had almost mature arborization 
patterns with complex and long branched dendrites, whereas 
cells overexpressing v-KIND had very simple dendritic arbori-
zation patterns with a few long and less-branched dendrites 
(Fig. 4 A). Total dendrite length of v-KIND-overexpressing 
cells (566 ± 216 μm) was less than that of cells expressing 
EGFP alone (1753 ± 421 μm; Fig. 4 C; P < 0.001). In addition, 
the number of dendritic branch tips per cell (branches with a 
Figure 4.  v-KIND overexpression in hippocampal neurons suppressed dendrite growth. Primary cultured hippocampal neurons were cotransfected 
by pCAG-v-KIND plus pCAG-EGFP at DIV3. Neurons at DIV11, DIV15, and DIV21 were ﬁ  xed and observed. Neurons overexpressing pCAG-EGFP 
alone were used as controls. (A) Images of neurons overexpressing v-KIND plus EGFP. Bar, 100 μm. (B) Statistical analysis of percentage of neurons 
with elongated dendrites. (C and D) Statistical analysis of total dendrite length (C) and dendrite arbor numbers (D) of individual neurons expressing v-KIND 
plus EGFP at DIV11, DIV15, and DIV21. In statistical analysis, data from at least three independent experiments are presented as mean ± SD. **, P < 
0.001(t test). The number of neurons counted is shown in the parentheses above the columns.JCB • VOLUME 179 • NUMBER 3 • 2007  544
distance from soma to tips longer than 20 μm were counted) 
was reduced by v-KIND overexpression (11 ± 5) compared 
with expression of EGFP alone (17 ± 5; Fig. 4 D; P < 0.001). 
These results demonstrate that overexpression of v-KIND in-
duces signifi  cant dendrite growth defects, including reduced 
elongation and branching.
v-KIND suppresses dendrite growth during 
development
To further analyze the function of v-KIND, we used RNAi to 
knockdown v-KIND expression. The knockdown effi  ciency of 
three types of stealth v-KIND RNAi constructs (RNAi-1, 2, 3) 
was confirmed in COS7 cells by cotransfecting cells with 
pEGFP-v-KIND (Fig. S2, A–D, available at http://www.jcb.org/
cgi/content/full/jcb.200702036/DC1). Hippocampal cultures were 
transfected with each v-KIND RNAi construct together with EGFP 
at DIV3 and the dendritic patterns of EGFP-positive neurons 
were analyzed at DIV21 (Fig. 5 A). In contrast to three control 
RNAi constructs (Control-1, -2, -3), all v-KIND RNAi constructs 
induced the formation of complex dendritic patterns with sig-
nifi  cantly increased dendrite branching and length (Fig. 5 A). 
The effi  ciency of v-KIND RNAi knockdown was verifi  ed by 
transfecting with the RNAi construct at DIV3 followed by 
analyzing endogenous v-KIND levels at DIV7 and DIV17. 
The representative data of RNAi-2 effects are shown in Fig. 5 
(C and D). In contrast to the Control-2, the RNAi-2 signifi  cantly 
reduced v-KIND immunoreactivity at both DIV7 and DIV17, 
indicating that the RNAi was effective for v-KIND knockdown 
for at least 2 wk after transfection. For statistical analyses, 
we combined all data obtained from the experiments transfect-
ing with each RNAi construct (RNAi-1, RNAi-2, or RNAi-3) 
and those from the control experiments transfecting with each 
  control construct (Control-1, Control-2, or Control-3). The av-
erage total dendrite length per cell transfected with the v-KIND 
RNAi construct and control RNAi was 2,359 ± 475 and 1,610 ± 
316 μm, respectively (Fig. 5 E). The average number of den-
dritic branch tips per cell was 35 ± 9.7 for v-KIND RNAi-
transfected cells and 24 ± 6 for control RNA-transfected cells 
(Fig. 5 F). These data indicated that RNAi-induced knockdown 
of cellular v-KIND expression enhanced dendrite growth (Fig. 5 E, 
P < 0.001) and complexity in hippocampal neurons (Fig. 5 F, 
P < 0.001).
Figure 5.  Knockdown of v-KIND in hippocampal neurons promoted dendrite growth. Neurons were transfected at DIV3, ﬁ  xed, immunolabeled, and ob-
served at DIV21. Bar, 100 μm. (A), EGFP images of hippocampal neurons transfected with single v-KIND RNAi construct (RNAi-1, -2, and -3) or control 
construct (Control-1, -2, and -3) plus pCAG-EGFP. (B) Hippocampal neurons overexpressing v-KIND, v-KIND plus RNAi-2 (v-KIND+RNAi-2), or v-KIND plus 
Control-2 (v-KIND+Control-2). (a–c) EGFP images of neurons; (d–f) neurons immunolabeled by anti-FLAG antibody. (C) v-KIND RNAi-2 effectively knocked 
down v-KIND expression in hippocampal neurons. Hippocampal neurons were transfected soon after dissociation (see Materials and methods). Cells 
were lysated at DIV7 and DIV17 as indicated. v-KIND expression levels were analyzed by immunoblotting with the anti-v-KIND antibody (top panel) 
and the anti-α-tubulin antibody was used as a quantity control (bottom panel). (D and E) Statistical analysis of total dendrite length (D) and dendrite arbor 
numbers (E) of individual neurons. Data obtained from single RNAi experiments (RNAi-1, -2, and -3) were combined for statistical analysis of RNAi effects, 
and those from single control experiments (Control-1, -2 and -3) were combined for statistical analysis of control effects. Data from at least three independent 
experiments are presented as mean ± SD. *, P < 0.01, and **, P < 0.001 (t test). The number of neurons counted is shown in the parentheses above 
the columns.MAP2-BINDING RASGEF V-KIND REGULATES DENDRITE GROWTH • HUANG ET AL. 545
To confi  rm the cellular effect induced by v-KIND knock-
down, we next investigated whether v-KIND RNAi rescued 
the dendritic phenotype induced by v-KIND overexpression. 
Hippocampal neurons were cotransfected with FLAG-tagged 
v-KIND plus RNAi-2 (v-KIND+RNAi-2) or with FLAG-
tagged v-KIND plus Control-2 (v-KIND+Control-2) at DIV3, 
and were observed at DIV21 (Fig. 5 B). v-KIND+Control-2 
transfected cells had simple and less branched dendritic patterns 
(Fig. 5 B, b), similar to those of v-KIND-overexpressing cells 
(Fig. 5 B, a). On the other hand, v-KIND+RNAi-2 transfected 
cells exhibited more complex dendritic patterns (Fig. 5 B, c). 
Exogenous FLAG-tagged v-KIND expression in transfected 
hippocampal neurons was visualized by immunostaining with 
anti-FLAG antibody (Fig. 5 B, d–f). In contrast to v-KIND 
and v-KIND+Control-2 (Fig. 5 B, d and e, respectively), 
v-KIND+RNAi-2 transfected cells had signifi  cantly decreased 
FLAG immunoreactivity (Fig. 5 B, f), indicating that RNAi 
effectively inhibited exogenous FLAG-tagged v-KIND. Similar 
results were also observed in RNAi-1 and RNAi-3 transfected 
cells. Statistical analysis by combining all data of these RNAi 
expression experiments (RNAi-1, -2, and -3) and their control 
experiments (Control-1, -2, and -3) indicated that the   average 
total dendrite length per cell transfected with v-KIND, v-KIND+
Control, and v-KIND+RNAi was 1,159 ± 381, 921 ± 317, and 
2,280 ± 332 μm, respectively (Fig. 5 E) and that the average 
number of dendritic branch tips was 15 ± 6, 14 ± 4, and 31 ± 8, 
respectively (Fig. 5 F). These data indicated that cotransfection 
with RNAi rescued retarded dendrite growth by v-KIND over-
expression with regard to both length (Fig. 5 E, P < 0.001) 
and branching (Fig. 5 F, P < 0.001). Collectively, these results 
suggest that v-KIND controls the development of dendritic arbori-
zation, probably by limiting dendrite growth, such as dendritic 
branching and extension.
v-KIND interacts with MAP2
To clarify the molecular mechanism underlying v-KIND-mediated 
control of dendrite growth, we analyzed v-KIND associated pro-
teins by coimmunoprecipitation from brain lysates with anti-
v-KIND antibody followed by MASS spectrometry analysis 
(Fig. 6 A). Silver staining after separating on sodium dodecyl 
sulfate-PAGE (SDS-PAGE) revealed a high molecular weight 
band of  280 kD specifi  cally precipitated by anti-v-KIND anti-
body, but not by rabbit IgG. This band was identifi  ed as MAP2 
by MASS spectrometry analysis (Fig. 6 A).
We fi rst examined the interaction between v-KIND and 
MAP2 by coimmunoprecipitation experiments using COS7 
cells lysates with exogenously coexpressed MAP2 and FLAG-
tagged v-KIND or various deletion mutants: mutants lacking 
the fi  rst KIND domain (∆ΚIND1), the second KIND domain 
(∆KIND2), RasN (∆RasN), or RasGEF (∆GEF). Anti-v-KIND 
antibody coimmunoprecipitated MAP2 coexpressed with v-KIND, 
∆KIND1, ∆RasN, and ∆GEF, but not ∆KIND2 (Fig. 6 B). 
These results suggest that v-KIND interacts with MAP2 via the 
KIND2 domain. To further confi  rm the MAP2 binding region of 
v-KIND, we performed pull down assays from mouse brain 
lysates using GST fusion KIND1 and KIND2 proteins. Immuno-
blotting and silver staining analyses showed that GST-KIND2, 
but not GST-KIND1, pulled down endogenous brain MAP2 
(Fig. 6 C, top). These results demonstrated that the KIND2 domain 
is responsible for interaction with MAP2.
We analyzed changes in the interaction between v-KIND 
and MAP2 during mouse brain development by coimmuno-
precipitation using anti-v-KIND and anti-MAP2 antibodies 
(Fig. 6 D; and Fig. S3, A and B, available at http://www.jcb
.org/cgi/content/full/jcb.200702036/DC1). The quantity of v-KIND 
that coimmunoprecipitated with MAP2 peaked at P14, and the 
quantity of MAP2 that coimmunoprecipitated with v-KIND 
sharply increased at P14 and decreased at P21. Thus, the peak 
stage for the association between v-KIND and MAP2   appears to 
parallel the mid-late developmental stage of dendrite development. 
In fact, colocalization of v-KIND with MAP2 in P21 mouse 
cerebellum was also detected in the IGL and in neurons of the 
deep cerebellar nuclei (Fig. S3, C–K).
v-KIND enhances Thr phosphorylation 
of MAP2
MAP2 is one of the most phosphorylated proteins in neurons 
and its phosphorylation state correlates with dendrite develop-
ment (Sanchez et al., 2000). We evaluated whether serine (Ser) 
and Thr phosphorylation levels of MAP2 expressed in COS7 
cells were affected by coexpression of v-KIND. Phosphorylated 
MAP2 was detected by immunoprecipitation with anti-MAP2 
antibody followed by immunoblotting with anti-phospho-Ser 
and anti–phospho-Thr (p-Thr) antibody (Fig. 6 E). Ser phos-
phorylation in MAP2 did not change signifi  cantly (unpublished 
data). In contrast, v-KIND coexpression increased p-Thr immuno-
reactivity of MAP2 (Fig. 6 E, top), which was confi  rmed by sta-
tistical analysis of quantifi  ed immunoreactive band intensity 
(Fig. 6 F, P < 0.05). These results suggested that coexpressed 
v-KIND enhances Thr phosphorylation of MAP2.
Many protein kinases phosphorylate MAP2 during brain 
development (Sanchez et al., 2000). ERK and JNK-1, down-
stream kinases of Ras signaling pathways, are involved in Thr 
phosphorylation of MAP2 (Holzer et al., 2001; Bjorkblom 
et al., 2005). We investigated the effects of the ERK1/2 inhibi-
tor U0126 (Favata et al., 1998) or the JNK-1 inhibitor SP600125 
(Bennett et al., 2001) on v-KIND induced p-Thr immuno-
reactivity of MAP2 (Fig. 6 G). U0126 or SP600125 treatment 
reduced Thr phosphorylation levels of MAP2 augmented by 
v-KIND coexpression, suggesting that JNK-1 and ERK, down-
stream targets of Ras signaling, are involved in the v-KIND–
mediated MAP2 phosphorylation.
v-KIND is anchored to MAP2 through the 
KIND2 domain
To study the protein structure and functional relationships of 
v-KIND in dendrite growth, we expressed various FLAG-tagged 
v-KIND constructs (v-KIND, ∆KIND1, ∆KIND2, ∆RasN, 
∆GEF, KIND1 domain, and KIND2 domain) in hippocampal 
cells and immunocytochemically analyzed by anti-FLAG anti-
body (Fig. 7). Overexpressed v-KIND was mainly distributed in 
the soma and dendrite shafts where MAP2 was concentrated 
(Fig. 7, A and C). Similar to v-KIND, ∆KIND1, ∆RasN, and 
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(Fig. 7 C). In contrast, ∆KIND2 was ubiquitously localized in 
the soma, dendrites shafts, spines, and axons (Fig. 7, B and C). 
Overexpressed KIND1 domain was widespread in dendrites 
and dendritic protrusions, including spines (Fig. 7, D and F), 
whereas overexpressed KIND2 domain had a similar localiza-
tion as v-KIND, and was mainly localized in dendritic shafts, 
but not in spines (Fig. 7, E and G). Because KIND2 strongly 
binds with MAP2 (Fig. 6 B), these results indicate that v-KIND 
is anchored to MTs via the KIND2 domain.
MAP2 is a target in the signal of v-KIND-
related regulation of dendrite development
KIND2 binds MAP2 as strongly as v-KIND protein, indicating 
that KIND2 is suffi  cient to replace endogenous v-KIND for MAP2 
binding (Figs. 6 and 7). We transfected the FLAG-tagged v-KIND 
or KIND2 domain into hippocampal neuronal primary cultures 
at DIV3, and observed the dendrite morphology at DIV11, 
DIV15, and DIV21 (Fig. 8). Expression of exogenous v-KIND 
and KIND2 proteins was confi  rmed by immuno  cyto  chemistry 
using anti-FLAG antibody (Fig. S4 A, available at http://www
.jcb.org/cgi/content/full/jcb.200702036/DC1). In contrast to 
KIND2 overexpression induced signifi  cant increase in the total 
dendrite length (Fig. 8 A, bottom three panels and Fig. 8 D; 
P < 0.001) and branching (Fig. 8 C, P < 0.05) compared with 
no expression of v-KIND constructs. These results demonstrate 
that the MAP2-binding KIND2 domain acts as a dominant 
negative form of v-KIND in the neuron, and that MAP2 is a 
target for v-KIND which controls dendrite growth. Moreover, it 
is noted that overexpression of the construct   containing both 
KIND1 and KIND2 domains (KIND1+2) in hippocampal neurons 
Figure 6.  v-KIND binds HMW MAP2 and induces its Thr phosphorylation. (A) Association of v-KIND with MAP2 in postnatal mouse cerebellum. Silver 
staining of proteins associated with v-KIND in P21 mouse cerebella which were coimmunoprecipitated by the anti-v-KIND antibody. Open arrowhead, 
v-KIND protein; solid arrowhead, a band of  280 kD. (B) Association of v-KIND mutants with MAP2. v-KIND and the deletion of the ﬁ  rst KIND (∆KIND1), 
deletion of the second KIND domain (∆KIND2), deletion of RasN (∆RasN), and deletion of RasGEF (∆GEF) were coexpressed in COS cells together with 
MAP2. Immunoprecipitations using the anti-v-KIND antibody were immunoblotted by anti-MAP2 antibody. (C) the KIND2 domain was responsible for MAP2 
binding in mouse cerebellum. Equal amounts of mouse cerebellar proteins pulled down by GST-KIND1 and GST-KIND2 were subjected to immunoblotting 
by anti-MAP2a/b antibody (top panel) and visualized by silver staining (bottom panel). Silver-stained bands in the rectangle as indicated by the arrows 
are GST fusion proteins used. Positive control, immunoprecipitations by anti-v-KIND antibody; negative control, GST. Solid arrowhead, a band of  280 kD 
(MAP2). (D) Developmental association of v-KIND with MAP2. Top two panels, quantity of MAP2 coimmunoprecipitated with v-KIND. Bottom two 
panels, quantity of v-KIND coimmunoprecipitated with MAP2. (E) v-KIND overexpression increased p-Thr levels of MAP2. MAP2 was coexpressed with or 
without FLAG-tagged v-KIND and then it was immunoprecipitated and followed by immunoblotting by the anti-p-Thr antibody. Top panel, MAP2 Thr 
phosphorylation; middle panel, MAP2 in immunoprecipitations; bottom panel, v-KIND in the whole-cell lysates (anti-FLAG antibody). (F) Band intensity from 
three independent experiments in E was quantiﬁ  ed by densitometry analysis and statistically analyzed. Relative band intensity with v-KIND overexpression 
to the MAP2 alone was shown. The data are presented as mean ± SD (F). *, P < 0.05 (t test). (G) ERK and JNK are involved in v-KIND induced MAP2 
Thr phosphorylation. MAP2 was overexpressed together with v-KIND, and cells were treated by inhibitors of ERK1/2 (U0126) at 10 μM or JNK-1 
(SP600125) at 25 μM for 2 h. Thr phosphorylation levels of treated and untreated MAP2 were checked by anti-p-Thr antibody.MAP2-BINDING RASGEF V-KIND REGULATES DENDRITE GROWTH • HUANG ET AL. 547
induced signifi  cant increases in both dendrite length (Fig. 8 F) 
and branching (Fig. 8 G) compared with overexpression of 
KIND2 alone (Fig. S4 B). These results suggest another binding 
partner of v-KIND via KIND1 might also be involved in v-KIND-
mediated regulation of dendrite growth and complexity and/or 
that the functional ability of KIND2 might be enhanced in the 
presence of KIND1.
V-KIND has an important role in the 
control of cerebellar granule cell dendrite 
development
We demonstrated the fundamental properties of v-KIND in hip-
pocampal neurons as described above. We then analyzed the 
role of v-KIND in dendrite growth of cerebellar granule cells 
was analyzed by a series of v-KIND overexpression and knock-
down experiments. Overexpression of v-KIND caused stunted 
short dendrites (Fig. 9, A and F, total dendrite length, P < 0.001) 
in cerebellar granule cells, whereas that of KIND2 alone in-
duced extended long dendrites (Fig. 9, A and G, total dendrite 
length, P < 0.05). These observations were very similar to those 
in hippocampal neurons. The effects of v-KIND knockdown on 
granule cells were analyzed by transfecting with each RNAi 
construct or each Control construct soon after cell dissociation 
followed by fi  xation for EGFP cell morphology imaging at 
DIV7 (Fig. 9 B). Western blot analyses showed effective knock-
down of v-KIND expression levels in RNAi-2-transfected cultures 
at DIV7 and DIV14 in comparison with those in Control-2-
transfected cultures (Fig. 9 C). In addition, v-KIND knockdown 
by RNAi-2 promoted dendrite growth in granule cell cultures 
compared with that with Control-2 (Fig. 9 G, P < 0.01), which 
was similar to hippocampal neurons shown in Fig. 5, A and D. 
These results indicated that v-KIND has an important role in the 
control of neuron dendrite development in both cerebellar gran-
ule cells and hippocampal neurons.
We investigated MAP2 Thr phosphorylation in cerebellar 
granule cells when endogenous v-KIND expression was knocked 
down by RNAi. Western blotting analysis and quantitative sta-
tistical analysis showed that MAP2 Thr phosphorylation was 
reduced concomitantly with decreased v-KIND levels by knock-
down with RNAi-2 (Fig. 9, D and E, P < 0.05). Similar data 
were also obtained from hippocampal neurons after v-KIND 
knockdown by RNAi (unpublished data). These results suggest 
that v-KIND is involved in MAP2 Thr phosphorylation, which 
is likely important for dendrite development.
Discussion
In this study, we characterized a novel function for a brain-
specifi  c, two KIND domain-containing Ras GEF, v-KIND pro-
tein. v-KIND had a widespread distribution pattern in mouse 
brain, and was predominantly expressed in the IGL of cerebel-
lum from around P12 to adult stage. In cerebellum, v-KIND 
protein was localized in the soma of granule cells and glomer-
uli, where granule cell dendrites extended to make synapses 
with mossy fi  bers and Golgi cell axons, and in hippocampus, 
it was present in the soma and dendrites of CA1-3 neurons. 
v-KIND activated Ras through the RasGEF domain and inter-
acted with MAP2 through the KIND2 domain. Overexpression 
of exog  enous v-KIND protein suppressed dendrite growth, whereas 
knockdown of v-KIND by RNAi promoted dendrite growth. 
These fi  ndings suggest a new signaling pathway linking small 
GTPase Ras and MT-associated MAP2 via v-KIND to control 
dendrite growth (Fig. S5, available at http://www.jcb.org/cgi/
content/full/jcb.200702036/DC1).
v-KIND links signaling of activated Ras 
to MAP2
v-KIND was fi  rst reported as a novel brain-specifi  c RasGEF 
(Mees et al., 2005). In the present study, v-KIND bound to 
and activated Ras in mouse brain lysates through the C-  terminal 
RasGEF domain, indicating that v-KIND certainly acts as a 
brain RasGEF. Within the GEF family, v-KIND is unique to 
Figure 7.  KIND2 domain anchors v-KIND to MT. Hippocampal neurons 
were transfected at DIV10, ﬁ  xed and immunolabeled by the anti-FLAG anti-
body. (A and B) Confocal images of neurons overexpressing v-KIND (A), 
∆KIND2 (B). (C) Localization of overexpressed v-KIND and deletion mu-
tants in dendrites. (D and E) Neurons (DIV21) with exogenously expressed 
KIND1 (D) and KIND2 domains (E). (F and G) Colocalization of exoge-
nously expressed KIND1 (F) and KIND2 (G) domains with MAP2 (blue, 
anti-Map2a/b). Bar, 100 μm.JCB • VOLUME 179 • NUMBER 3 • 2007  548
have two KIND domains at the N-terminal region. The KIND 
domain is a recently identifi  ed protein domain whose func-
tional properties remain yet unclear (Ciccarelli et al., 2003). 
Our results demonstrated that the KIND2 domain is functionally 
distinct from the KIND1 domain and specifi  cally interacts with 
MAP2 in in vitro expression systems and in vivo brain lysates. 
In addition, overexpressed KIND2 was concentrated in dendritic 
shafts of neurons and largely colocalized with MAP2. These 
results suggest that v-KIND is anchored to the dendrites through 
the interaction between the KIND2 domain and MAP2.
MAP2 contains a number of Ser and Thr residues that are 
highly conserved in mouse, rat, and human, and many of these 
residues are highly phosphorylated in vivo (Sanchez et al., 
2000). Both ERK and JNK-1 are downstream molecules of 
the Ras signaling pathways and are involved in Thr phosphory-
lation of MAP2 (Holzer et al., 2001; Bjorkblom et al., 2005). 
Our results showed that v-KIND induced MAP2 Thr phosphory-
lation, which was blocked by inhibitors of ERK or JNK-1. 
These results suggest that v-KIND links the Ras signaling cas-
cades, including downstream signaling via ERK or JNK1, to 
MAP2 phosphorylation.
v-KIND controls dendrite growth
The v-KIND overexpression and RNAi knockdown experiments 
suggested important roles of v-KIND in controlling dendrite 
growth, although the underlying molecular mechanism remains 
elusive. One possibility might be the physical and functional as-
sociation between v-KIND and MAP2, that is, v-KIND-MAP2 
interaction and v-KIND-induced MAP2 Thr phosphorylation. 
During dendrite development, normal MT structures are re-
quired for both dendritic elongation at early stages and dendritic 
maturation at later stages. MAP2 phosphorylation levels are de-
velopmentally controlled along with dendrite growth (Riederer 
et al., 1995; Quinlan and Halpain, 1996). Increased phosphory-
lation of MAP2 causes MAP2 to detach from MTs, resulting in 
decreased MT stability and attenuated actin-bundling activity 
(Jameson and Caplow, 1981; Murthy and Flavin, 1983; Selden 
and Pollard, 1983; Hoshi et al., 1992; Sanchez et al., 2000). 
Our results showed that v-KIND overexpression promotes MAP2 
Thr phosphorylation and causes impaired dendrite growth, whereas 
v-KIND RNAi knockdown reduces MAP2 Thr phosphorylation 
and induces increased dendrite growth. Moreover, we showed 
that the MAP2-binding domain KIND2 alone acts as a dominant 
Figure 8.  Overexpression of the KIND2 domain promotes dendrite growth. Hippocampal neurons were transfected at DIV3, neurons were ﬁ  xed and ob-
served at DIV11, DIV15, and DIV21. Bar, 100 μm. (A) Representative images of hippocampal neurons overexpressing EGFP, v-KIND plus EGFP, or the 
KIND2 domain plus EGFP. (B–D) Statistical analysis of the percentage of neurons with elongated dendrites at DIV11 (B), dendritic tip numbers at DIV21 
(C), and total length of dendrite branches (D) in individual neurons expressing EGFP, v-KIND, or KIND2. (E) Representative images of hippocampal neurons 
overexpressing the KIND2 domain, or the KIND1+2 domains of the v-KIND protein. (F and G) Statistical analysis of total dendrite length (F) and average 
dendritic tip number (G) of individual neurons. In statistical analysis, data from at least three independent experiments are presented as mean ± SD. *, P < 0.05, 
**, P < 0.001 (t test). The number of neurons counted is shown in the parentheses above the columns.MAP2-BINDING RASGEF V-KIND REGULATES DENDRITE GROWTH • HUANG ET AL. 549
negative and its overexpression eventually increases dendrite 
length and complexity. These data suggest a possibility that 
v-KIND functions through controlling of MAP2 phosphorylation 
levels during dendrite development.
The present study showed that v-KIND might associate 
with other cytoskeletal element(s) via the KIND1 domain ex-
cept for the interaction with MAP2 via the KIND2 domain. 
In this regard, it is notable that overexpression of the con-
struct containing both KIND domains (KIND1+2) induced 
more branching and longer dendritic patterns than that of the 
KIND2 domain alone. Moreover, although v-KIND promi-
nently colocalized with MAP2 in dendritic shafts, it was also 
observed in dendritic terminals where it partially colocalized 
with F-actin in developing hippocampal neurons. Altogether, 
these results suggest that apart from MAP2, other binding 
partner(s) may also cooperate with v-KIND in controlling com-
plex dendrite development.
Functional role of v-KIND in cerebellar 
development
Dendrite growth and complexity appear to be regulated by a 
combination of positively and negatively acting factors in den-
drite growth (Scott and Luo, 2001). Hippocampal neurons and 
cerebellar granule cells have different complexities in dendritic 
patterns, and hippocampal neurons have much longer and more 
complicated dendrite patterns than cerebellar granule cells. 
  Cerebellar granule cells possess very short, claw-like dendrites 
around the mossy fi  ber terminals within the glomerular rosettes. 
These dendrites not only make excitatory synapses with large 
mossy terminals, but also form inhibitory synapses with Golgi 
cell axon terminals within the synaptic glomeruli (Ito, 1997). 
Moreover, in addition to synaptic contacts, these dendrites form 
numerous dendrodendritic attachment plaques or puncta adher-
entia in glomeruli. Whether the differences in the dendrite com-
plexity between hippocampal neurons and cerebellar granule 
Figure 9.  v-KIND has an important role in the control of cerebellar granule cell dendrite development. (A) Confocal images of cerebellar granule cells 
overexpressing EGFP, v-KIND plus EGFP, or KIND2 plus EGFP. (B) Confocal images of cerebellar granule cells transfected with v-KIND RNAi (RNAi-1, -2, 
and -3) or the control RNA (control-1, -2, and -3). Cerebellar granule cells were transfected by the calcium phosphate method using a CellPhect Transfection 
kit at DIV1, and cells were ﬁ  xed at DIV7. Imaging of the marker protein EGFP shows the neuron morphology. (C) Knockdown of v-KIND was conﬁ  rmed by 
immunoblotting with anti-v-KIND antibody. RNAi constructs (Control-2 or RNAi-2) were transfected into cerebellar granule cells soon after dissociation using 
the Mouse Neuron Nucleofector kit and the Nucleofector device (Amaxa). Cells were lysed at DIV7 and DIV14, respectively. Immunoblotting was per-
formed with the anti-v-KIND antibody (top panel), and anti-α-tubulin antibody was used as a quantity control (bottom panel). (D) MAP2 Thr phosphorylation 
was reduced by v-KIND knockdown. The data of RNAi-2 are shown. Top panel, immunoblotting with the anti-phosphorylated Thr antibody (p-Thr); middle 
panel, immunoprecipitated MAP2; bottom panel, immunoblotting by anti-v-KIND antibody. (E) Quantitative analysis of intensities of MAP2 Thr phosphory-
lation band and v-KIND band in v-KIND RNAi-2 or control-2 transfected cells from three independent experiments (see Materials and methods). Relative in-
tensity to the control was shown (% control) as mean ± SD. *, P < 0.05 (t test) as compared with the control. (F) Statistical analysis of the total dendrite 
length of cerebellar granule cells overexpressing EGFP, v-KIND plus EGFP, and KIND2 plus EGFP. (G) Statistical analysis of the total dendrite length of cere-
bellar granule cells transfected with RNAi-2 plus EGFP (RNAi-2), or Control-2 plus EGFP (Control-2). In statistical analysis, data from at least three indepen-
dent experiments are presented as mean ± SD. *, P < 0.05, **, P < 0.01, ***, P < 0.001 (t test). The number of neurons counted is shown in the 
parentheses above the columns.JCB • VOLUME 179 • NUMBER 3 • 2007  550
cells are, at least in part, caused by differential levels of protein 
expression is not known.
We initially isolated v-KIND as a gene predominantly 
expressed in cerebellar granule cells of the IGL during mid-late 
developmental stages of postnatal mouse brain. v-KIND immuno-
reactivity was enriched in the somatodendritic regions of granule 
cells and especially the glomeruli. Moreover, we demonstrated 
that v-KIND overexpression suppresses the dendrite growth of 
cerebellar granule cells, whereas v-KIND knockdown promotes 
it. Thus, we suggest that v-KIND acts as a signaling molecule in 
controlling or limiting dendrite growth to form short but unique 
structures that extend within very narrow spaces and are sur-
rounded by densely packed granule cell soma in the IGL during 
the mid-late developmental period. Slight differences observed 
in the extent of the effects of v-KIND overexpression and 
knockdown between cerebellar granule cells and hippocampal 
neurons might be due to differences in the expression levels 
of v-KIND, which negatively controls dendrite growth, as well 
as any positively acting factors in dendrite growth in these two 
cell-types.
Materials and methods
RT-PCR analysis
A series of ﬁ  rst-strand cDNAs was produced by reverse-transcription (RT) 
from 20 ng of total cerebellar RNAs at varying developmental stages, using 
an oligo-dT primer. The cDNA sequence corresponding to the nucleotide 
positions 583 to 1182 (a.a 175–394) of v-KIND (GenBank/EMBL/DDBJ 
accession no. AJ580324) was ampliﬁ  ed using the primers 5′-G  C  A  G  G  T-
G  G  G  G  A  A  A  A  C  T  C  C  -3′ (forward primer) and 5′-C  T  G  G  C  G  T  C  T  C  C  A  G  C  A  A-
A  T  -3′ (reverse primer). The cycling conditions were as follows: denaturing 
at 94°C for 3 min, ampliﬁ  cation by 25 cycles at 94°C (15 s), 55°C (30 s), 
and 72°C (1 min), and extension at 72°C for 5 min. To analyze tissue dis-
tribution, total RNAs prepared from various tissues of P7 or P21 mice were 
used for RT-polymerase chain reaction (PCR). The RT-PCR of glyceraldehyde-
3-phosphate dehydrogenase with primers 5′-G  C  C  A  T  C  A  A  C  G  A  C  C  C  C  T  T  C  A  T-
T  G  A  C  C  T  C  -3′ (forward primer) and 5′-G  C  C  A  T  G  T  A  G  G  C  C  A  T  G  A  G  G  T  C  C  A  C-
C  A  C  -3′ (reverse primer) were used as internal controls.
In situ hybridization
In situ hybridization (ISH) brain histochemistry was basically performed as 
described previously (Huang et al., 2006). The cDNA sequence corre-
sponding to nucleotide positions 1962 to 2561 (a.a 654–857) of the 
v-KIND cDNA was used as a template to prepare the digoxigenin-labeled 
antisense riboprobes using a digoxigenin-dUTP labeling kit (Roche Diag-
nostics). Parafﬁ  n sections of mouse brain (10 μm thick) were ﬁ  xed in 4% 
paraformaldehyde for 5 min, washed twice in phosphate buffered saline 
(PBS), and treated with freshly prepared 10 μg/ml proteinase K (Invitro-
gen) at room temperature. After acetylation, the sections were subjected to 
digoxigenin-based hybridization procedures. In brief, the sections were in-
cubated in hybridization buffer containing 0.2 μg/ml digoxigenin-labeled 
riboprobes at 60°C overnight in a humid chamber. The hybridized sections 
were washed by successive immersion in 1 × SSC (150 mM NaCl and 
15 mM sodium citrate, pH 7.0; 60°C, 10 min, twice), 2 × SSC (37°C, 
10 min), 2 × SSC containing 20 μg/ml RNase A (37°C, 30 min), 2 × SSC 
(37°C, 10 min), and 0.2 × SSC (60°C, 30 min, twice). The hybridization 
signals were detected using a digoxigenin detection kit (Roche Diagnostics). 
ISH images (Fig. 1) were captured with a microscope (Olympus BX51) 
equipped with a 2×/NA 0.08 (PlanApo) or 20x/NA 0.7 (UPlanApo) 
objective and a charged-coupled device camera (ProgRes C14; JENOPTIK) 
and processed with Photoshop (Adobe).
Cell culture
COS-7 cells were grown in culture dishes in DME/10% fetal bovine serum 
at 37°C and 10% CO2 in a humidiﬁ  ed incubator. Hippocampal dissoci-
ated primary cultures were prepared from embryonic day 17 Wistar rats 
(Nippon SLC) as described previously (Shiraishi et al., 2003). In brief, ex-
cised hippocampi were treated with 45 U papain (Worthington), 0.01% 
DNase I (Boehringer-Mannheim), 0.02% DL-cystein, 0.02% bovine serum 
albumin, and 0.5% glucose in PBS for 20 min at 37°C. After adding 20% 
bovine serum, cells were dissociated by repeatedly passing them through 
a 1 ml plastic pipette tip. Dispersed cells were plated at a density of 1.10
4 
cells/cm
2 onto poly-L-lysine-coated (Sigma-Aldrich) glass coverslips (Matsu-
nami) in neurobasal medium (GIBCO BRL, Life Technologies) containing 
2% B27 supplement (Invitrogen), 500 μM L-glutamine, 0.1 mg/ml strepto-
mycin (Meiji), and 100 U/ml penicillin (Banyu, Tokyo, Japan). Cultures 
were maintained in a humidiﬁ  ed atmosphere of 5% CO2 in air at 37°C.
Antibodies
Antibodies against mouse v-KIND were generated by immunizing rabbits 
with a synthetic peptide, C  E  K  H  S  R  K  I  Q  D  K  L  R  R  M  K  A  T  F  Q   (aa1724–1742), af-
ter conjugation with keyhole limpet hemocyanin. Afﬁ  nity puriﬁ  cation of the 
antibody was performed using a HiTrap NHS-High Performance column 
(Amersham Biosciences). The antibody was used at a dilution of 1:2000 
for immunoblotting and 1:1,000 for immunohistochemistry and immuno-
cytochemistry. Antibodies against MAP2a/b (M1406) and MAP2 (M4403) 
were obtained from Sigma-Aldrich; the antibody against GFP (SC-9996) 
was from Santa Cruz Biotechnology, Inc.; the anti-p-Thr antibody (#9381) 
was from Cell Signaling Technology; and the antibody against FLAG 
(F3165) was from Sigma-Aldrich. All antibodies were used at a dilution of 
1:1,000 in immunoblotting and 1:200 in immunohistochemistry and 
immunocytochemistry.
Plasmid construction
Mouse v-KIND was isolated by PCR from mouse cerebellum and cloned 
into a pCAG vector with a FLAG-tag (a gift from Dr. Junichi Miyazaki, Div. 
Stem Cell Regulation Research, Osaka University Graduate School of 
Medicine, Osaka, Japan). v-KIND mutants were prepared by PCR-based 
methods and inserted into pCAG vectors with a FLAG-tag. H-Ras cDNA 
was isolated by PCR from mouse cerebellum and cloned into a pCAG vec-
tor with a HA-tag. HMW MAP2 cDNA was a gift from Dr. N. Cowan (NYU 
Medical Center, New York, NY) and was constructed by PCR-based meth-
ods and cloned into pCAG vector with a HA-tag. KIND1 and KIND2 do-
main fragments were prepared by PCR-based methods, and were inserted 
into pGEX-4T-2.
Transfection and data analysis
COS-7 cells were transfected by Lipofectamine 2000 reagent (Invitrogen) 
24 h after plating at a density of 2.0 × 10
5 cells/cm
2. After an addi-
tional 6 h of incubation, cells were washed and cultured in DME/10% 
fetal bovine serum for 2 d. Hippocampal neurons were transfected by 
the Ca
2+-phosphate-mediated method with some modiﬁ  cation   (Haubensak 
et al., 1998; Kohrmann et al., 1999). For 10
5 cells plating on each cover-
slip, 2 μg of plasmid was dissolved in 10 μl 250 mM CaCl2, mixed 
with 10 ml 2×BBS (280 mM NaCl, 1.5 mM Na2HPO4, 50 mM BES, 
pH 7.1), and added to 400 μl of the fresh culture medium. After incuba-
tion for 1 to 2 h at 37°C with 2.5% CO2, cells were washed with HBSS 
and cultured in conditioned medium. The calcium phosphate method using 
a CellPhect Transfection kit (Amersham Biosciences) was used to trans-
fect cerebellar neurons on DIV1 in serum-free deﬁ  ned medium on poly-
L-lysine-coated glass coverslips. To quantify the percentage of cells with 
elongated dendrites at DIV11, 20 ﬁ  elds were randomly selected from 
three independent experiments with v-KIND or KIND2 overexpression based 
on healthy morphology, then analyzed by counting the number of cells 
with dendrites that were longer than 20 μm. To quantify dendritic length 
and arbor numbers in neurons overexpressing v-KIND protein or KIND2 
domain, dendritic length and the number of arbors of neurons randomly 
selected from three independent experiments (15 ﬁ  elds total) were mea-
sured. Results are presented as the mean ± SD and were analyzed with 
t test using the Excel 2003 software program. P values less than 0.05 were 
considered signiﬁ  cant.
RNAi
Three types of v-KIND stealth RNAi were obtained from Invitrogen. Their 
sense sequences were as follows: C  A  U  C  C  A  G  G  A  G  G  A  A  U  U  U  G  C  C  U  U  U  G  A  U   
(control sequence C A  U  G  G  A  G  G  A  U  A  A  G  U  U  U  C  C  U  U  C  C  G  A  U  ), G A  G  C  A  G  C-
U  G  C  U  A  A  A  G  A  A  C  C  U  C  U  U  C  A   (control sequence G A  G  G  U  C  G  A  A  U  C  A  A  G  A-
C  U  C  C  U  A  C  U  C  A  ), and G  A  G  A  C  G  G  G  A  G  G  U  U  U  C  A  C  C  A  U  G  A  C  U  A   (control 
sequence G  A  G  G  G  A  G  G  A  U  U  U  C  A  C  U  A  C  A  G  A  C  C  U  A  ). These RNAi were 
transfected into COS cells using the Lipofectamine 2000 reagent according 
to the manufacture’s directions (Invitrogen), and into hippocampal neurons 
together by pCAG-EGFP by Ca
2+ phosphate precipitation at a concentra-
tion of 50 nM as described above. For immunoblotting experiments, RNAi MAP2-BINDING RASGEF V-KIND REGULATES DENDRITE GROWTH • HUANG ET AL. 551
was transfected into cerebellar granule cells soon after dissociation using 
the Mouse Neuron Nucleofector kit and the Nucleofector device as previ-
ously described (Amaxa) (Huang et al., 2002; Liu et al., 2003).
Immunohistochemistry and immunocytochemistry
ICR mice were anesthetized with diethyl ether and transcardially perfused 
with 4% paraformaldehyde in PBS. The excised brains were immersed for 
2 h in the same ﬁ  xative and cryosectioned (20 μm thick). For immunohisto-
chemistry (IHC), ﬁ  xed brain sections were preincubated with 5% normal 
goat serum in PBS containing 0.03% Triton X-100 for 1 h and then incu-
bated with primary antibody overnight at 4°C. After washing with PBS, 
immunodetection was performed using horseradish peroxidase-conjugated 
secondary antibody (1:500) and diaminobenzidine. IHC images (Fig. 1) 
were captured with a microscope (Olympus BX51) equipped with a 2x/
NA 0.08 (PlanApo) or 20x/NA 0.7 (UPlanApo) objective and a charged-
coupled device camera (ProgRes C14; JENOPTIK). The acquired images 
were processed with Photoshop (Adobe). For immunocytochemistry, cul-
tured cells were ﬁ  xed with 4% paraformaldehyde with 4% sucrose, perme-
abilized in 0.2% Triton X-100 in PBS for 5 min at room temperature, 
preincubated with 5% normal donkey serum in PBS for 1 h, and then incu-
bated with each afﬁ  nity-puriﬁ  ed antibody for 16 h at 4°C. Multiple staining 
was performed using combinations of rabbit anti-v-KIND antibody 
(1:1,000), mouse anti-MAP2 antibody (1:200; Sigma-Aldrich), mouse 
anti-Flag antibody (1:200; Sigma-Aldrich), and Alexa 647-phallotoxin 
(1:50; AlexaFluor 647 phalloidin; Invitrogen). For ﬂ  uorescent  immuno-
staining, cells were then incubated with AlexaFluor 488-, 555-, or 647-
conjugated secondary antibody (Invitrogen) in 5% donkey serum/PBS for 
1 h at room temperature. Immunoﬂ  uorescent images were captured with a 
confocal microscope (LSM 510 META; Carl Zeiss MicroImaging, Inc.) 
equipped with a 20x/NA 0.50 (Plan-NEO FLUAR), 40x/NA 0.75 (Plan-NEO 
FLUAR), or 100x/NA 1.4 oil iris (Plan-APO CHROMAT) objective lens 
(20×, Fig. 8; 40×, Figs. 4, 5, and 7; 100×, Figs. 3 and 9) and LSM 510 
META software (Carl Zeiss MicroImaging, Inc). The acquired images were 
processed with Photoshop (Adobe).
Protein extraction, immunoprecipitation, and immunoblotting
Protein extraction and Western blotting analysis were performed as de-
scribed previously (Huang et al., 2006). In brief, COS cells or mouse cere-
bella were lysed and homogenized in 1% Triton X-100 buffer (50 mM 
Hepes, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl2, 
1 mM EGTA, 100 mM NaF, 1 mM Na3VO4, 10 μg/ml aprotinin, 10 μg/ml 
leupeptin, and 1 mM phenylmethylsulfonylﬂ  uoride). The subcellular frac-
tionation of the P7 and P21 mouse cerebella was performed as described 
previously (Huang et al., 2006). In brief, the P7 and P21 mouse cerebella 
were ﬁ  rst homogenized in homogenization buffer (0.32 M sucrose, 5 mM 
Tris·HCl, 1 mM EGTA, 1 mM dithiothreitol, 1mM pepstatin A, 1mM leu-
peptin, and 1mM Na3VO4). The protein lysates were centrifuged at 1,000 g 
for 10 min, the pellet was lysed in 1% Triton X-100 buffer (PPt1), and the 
supernatant was centrifuged at 105,000 g for 1 h. The pellet was lysed in 
1% Triton X-100 buffer (PPt2+3), and the supernatant was used as Sup3. 
For immunoprecipitation, after centrifuging at 1,000 g for 10 min, protein 
solutions (containing  1 mg protein) were mixed with the primary anti-
body and incubated for 1 h on ice. The mixtures were rotated with Protein A 
sepharose or Protein G sepharose (Amersham Biosciences) for 1 h at 
4°C. The sepharose was washed four times with 1% Triton X-100 buffer. 
After boiling in sample buffer (0.4 M Tris-HCl, pH 6.8, 8% SDS, 40% glyc-
erol, and 0.04% bromophenol blue) for 5 min, equal portions of protein 
solution were separated by SDS-PAGE and probed with diluted primary 
and horseradish peroxidase-conjugated secondary antibodies (1:2,000). 
Silver staining was performed using the silver staining kit according to the 
manufacturer’s instructions (Daiichi Pure Chemicals Co.). The GST fusion 
protein pull-down assay was performed as follows. Escherichia coli ex-
pressing GST fusion proteins were lysed with lysis buffer (50 mM Tris-HCl, 
pH 7.4, 25% sucrose, 1% Triton X-100, 5 mM MgCl2), and the cell extracts 
containing  10 μg GST-fusion proteins were coupled to glutathione-
sepharose (Amersham Biosciences) by rotating for 1 h at 4°C. After washing 
three times with 1% Triton-X/PBS, the sepharose was coupled to cerebellar 
protein lysates, which had been precleared with glutathione-sepharose for 
1 h at 4°C. After rotating for 1 h at 4°C, the GST-fusion protein complex 
was washed 5 times with cell lysis buffer and subjected to SDS-PAGE and 
immunoblotting. In GTP-γ-S and GDP-β-S treatment, protein lysates were 
treated with 0.1 mM GTP-γ-S (Sigma Chemical Co.) or 1.0 mM GDP-β-S 
(Sigma-Aldrich) in the presence of 10 mM EDTA, pH 8.0 at 30°C for 
15 min (to activate or inactivate Ras). Then the GST pull-down assay was per-
formed as described above. Quantitative analysis of immunoblotting band 
intensity was performed by Quantity-One software (Bio-Rad Laboratories). 
Relative intensity to the control was shown (% control). Values are mean ± SD. 
*, P < 0.05 as compared with the control.
Mass spectrometry
For identiﬁ  cation of v-KIND interacting proteins, in-gel digestion was per-
formed following Coomassie staining, bands corresponding to MAP2 were 
excised, and the gel pieces were destained with 50% CH3CN in 50 mM 
NH4HCO3 solution. After removing the supernatant, cysteine residues were 
reduced with dithiothreitol, carbamido methylated with iodoacetamide, 
and the proteins were digested with trypsin at 37°C overnight. The tryptic 
peptides were recovered by sequentially adding 50% CH3CN/1% triﬂ  uo-
roacetic acid, 20% HCOOH/25% CH3CN/15% i-PrOH, and 80% 
CH3CN solutions. The supernatants were collected and pooled into one 
tube, and the volume was reduced in vacuo. The dried tryptic peptides 
were suspended in 2% CH3CN/0.1% triﬂ  uoroacetic acid and applied to 
the following liquid chromatography-tandem mass spectroscopy system. 
Chromatographic separation was accomplished with the MAGIC 2002 
HPLC system (Michrom BioResources, Inc.). Peptide samples were loaded 
onto a Cadenza C18 custom-packed column (0.2 × 50 mm, Michrom Bio-
Resources, Inc.), and eluted using a linear gradient of 5% to 60% CH3CN 
in 0.1% HCOOH for 30 min with a ﬂ  ow of 1 ml/min. Samples were ion-
ized with the Nanoﬂ   ow-liquid chromatography electrospray ionization, 
and tandem mass spectrometry data were obtained with an LCQ-Deca XP 
ion trap mass spectrometer (Thermo Electron Corp.). The Mascot database 
searching software (Matrix Science Inc.) was used for the identiﬁ  cation of 
acetylated proteins.
Online supplemental material
Fig. S1: subcellular distribution of v-KIND in mouse cerebellum. Fig. S2: 
three oligonucleotide Stealth v-KIND RNAi efﬁ  ciently knocked down exog-
enously expressed v-KIND in COS7 cells. Fig. S3: association of v-KIND 
with MAP2. (A-B), Coimmunoprecipitation of v-KIND and MAP2 from brain 
lysate. Fig. S4: FLAG-tagged v-KIND protein and the mutant overexpressed 
in hippocampal neurons. Fig. S5. v-KIND links Ras signaling to MTs. v-KIND 
is anchored to the dendritic shaft through the KIND2 domain by its MAP2 
binding afﬁ  nity. Online supplemental material is available at http://www
.jcb.org/cgi/content/full/jcb.200702036/DC1.
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